Christopher F. Wyatt - 17 Feb 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: SVP & Controller
Signature: /s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 17 Feb 2023
Transactions value $: -$628,976
Form type: 4
Filing time: 22 Feb 2023, 19:11:13 UTC
Previous filing: 01 Feb 2023
Next filing: 02 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+6.08K	+18.77%	$0.00	38.5K	17 Feb 2023	Direct	F1
transaction	HCA	Common Stock	Tax liability	-$629K	-2.39K	-6.22%	$262.84	36.1K	17 Feb 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 29, 2020, the reporting person was granted 3,040 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

Content

On January 29, 2020, the reporting person was granted 3,040 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted.